Skip to main content
Clinical Trials/RBR-2mfbkkk
RBR-2mfbkkkNot yet recruiting未知

Clinical study of the application of Photobiomodulation in treatment of Dysgeusia in post-COVID-19 patients

Pontifícia Universidade Católica de Campinas0 sitesStarted: March 7, 2022Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Intervention

Eligibility Criteria

Ages
18Y to 0 (—)

Inclusion Criteria

  • Tested positive for coronavirus (COVID-19) after the Reverse Transcriptase Reaction followed by Polymerase Chain Reaction (RT-PCR) examination and who complained of symptoms of dysgeusia; Patients aged 18 years or older; Patients who are not in the disease transmission phase (fifteen days after the onset of symptoms); Patients who accept to be part of the research by signing the Free and Informed Consent Term; Patients who underwent gustatory dysfunction assessment tests and dysgeusia was confirmed

Exclusion Criteria

  • Patients who tested negative for coronavirus (COVID-19) after the Reverse Transcriptase Reaction followed by Polymerase Chain Reaction (RT-PCR) test; No complaints of dysgeusia symptoms; Under 18 years old; Pregnant and/or lactating patients; Patients who do not accept to participate in the research or who do not sign the Free and Informed Consent Form

Investigators

Sponsor
Pontifícia Universidade Católica de Campinas

Similar Trials